According to many findings associated with Tranilast, this drug that has been prescribed for many years can help in controlling inflammation, which even act as an effective antichemotactic factor, thereby resulting in an improvement in severe COVID-19 by preventing key inflammatory transcription factors like NF-jB and inhibiting NLRP-3 inflammasome. Some studies have further demonstrated the direct effect of this drug on the prevention of inappropriate tissue remodeling, which is one of the pathological events of this disease.